Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
Auction 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about NBIX
Recent news which mentions NBIX
< Previous
1
2
3
4
5
Next >
The Daily Biotech Pulse: FDA Orphan Drug Tags For Neurocrine, Editas Candidates; Sale of BridgeBio's PRV; RMAT Designation For PolarityTE's Product
May 13, 2022
Tickers
BBIO
BFRI
BMY
BTTX
Tags
News
Trading Ideas
Market News
From
Benzinga
Neurocrine Biosciences (NBIX) Q1 2022 Earnings Call Transcript
May 05, 2022
Tickers
NBIX
Tags
Recent Press Releases
NBIX
Market News
From
Motley Fool
Neurocrine Biosciences: Q1 Earnings Insights
May 04, 2022
Tickers
NBIX
Tags
Benzinga
News
BZI/Recaps
From
Benzinga
Neurocrine Biosciences Q1 2022 Earnings Conference Call On May 4, 2022 At 08:00 AM ET
April 25, 2022
Tickers
NBIX
Tags
News
Benzinga
NBIX
From
Benzinga
What 8 Analyst Ratings Have To Say About Neurocrine Biosciences
April 04, 2022
Tickers
NBIX
Tags
Benzinga
BZI/AAR
NBIX
From
Benzinga
The Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, Q1 Warning; Decision Day For Akebia
March 29, 2022
Tickers
AKBA
ALDX
AMPE
ATRS
Tags
NBIX
IMAB
Penny Stocks
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2022
March 03, 2022
Tickers
ALGT
AORT
AVTX
BALY
Tags
INTC
BXSL
SCPL
From
Benzinga
Where Neurocrine Biosciences Stands With Analysts
February 25, 2022
Tickers
NBIX
Tags
Benzinga
NBIX
BZI/AAR
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 25, 2022
February 25, 2022
Tickers
AAOI
AMED
AMPG
AXON
Tags
KRC
EVBG
DISH
From
Benzinga
Looking Into Neurocrine Biosciences's Return On Capital Employed
February 14, 2022
Tickers
NBIX
Tags
BZI/ROCE
NBIX
Market News
From
Benzinga
Neurocrine Biosciences (NBIX) Q4 2021 Earnings Call Transcript
February 11, 2022
Tickers
NBIX
Tags
Recent Press Releases
Market News
NBIX
From
Motley Fool
Why Neurocrine Biosciences Are Trading Higher Today?
February 11, 2022
Tickers
NBIX
Tags
Earnings
Biotechnology
Biotech
From
Benzinga
The Daily Biotech Pulse: Adcom Recommends Additional Trials For Lilly's Partnered Cancer Drug, Novavax Touts Pediatric Vaccine Data, TC Biopharm IPO
February 11, 2022
Tickers
BIO
DXCM
FRLN
GRAY
Tags
IPOs
ISEE
IBB
From
Benzinga
Recap: Neurocrine Biosciences Q4 Earnings
February 11, 2022
Tickers
NBIX
Tags
BZI/Recaps
NBIX
Market News
From
Benzinga
Earnings Scheduled For February 11, 2022
February 11, 2022
Tickers
AB
APO
ARES
AXL
Tags
DCUE
WPC
AXL
From
Benzinga
A Preview Of Neurocrine Biosciences's Earnings
February 10, 2022
Tickers
NBIX
Tags
Benzinga
NBIX
Earnings
From
Benzinga
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
Tickers
ABBV
ACLX
ALNY
AMGN
Tags
RARE
BIIB
ALNY
From
Benzinga
Analyst Ratings For Neurocrine Biosciences
February 01, 2022
Tickers
NBIX
Tags
Benzinga
NBIX
BZI/AAR
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2022
January 18, 2022
Tickers
ABNB
ADTH
AGI
AHI
Tags
DAL
Analyst Ratings
ENTG
From
Benzinga
10 Biggest Price Target Changes For Tuesday
January 18, 2022
Tickers
AVB
BIIB
EAT
JBHT
Tags
Price Target Changes
UAA
Health Care
From
Benzinga
Xenon Receives $15M Regulatory Milestone Under Epilepsy Pact With Neurocrine
January 12, 2022
Tickers
NBIX
XENE
Tags
Biotech
General
Benzinga
From
Benzinga
Analyst Ratings For Neurocrine Biosciences
January 07, 2022
Tickers
NBIX
Tags
Benzinga
Analyst Ratings
Market News
From
Benzinga
The Daily Biotech Pulse: Glaukos Gets FDA Nod, Neurocrine Preannounces Soft Ingrezza Sales, 3 IPOs
January 07, 2022
Tickers
AMLX
CINC
FDMT
GKOS
Tags
ICUI
IBB
GKOS
From
Benzinga
Expert Ratings For Neurocrine Biosciences
December 08, 2021
Tickers
NBIX
Tags
Benzinga
NBIX
BZI/AAR
From
Benzinga
The Daily Biotech Pulse: Valneva Strikes Deal To Supply COVID Vaccine to Bahrain, TherapeuticsMD & Amneal Settle Patent Lawsuit, Reata Awaits Adcom
December 08, 2021
Tickers
ACET
AMAM
AMRX
BIIB
Tags
General
BIIB
NUVB
From
Benzinga
Neurocrine's Ingrezza Meets Primary Goal In Phase 3 Study In Patients With Involuntary Muscle Movement
December 08, 2021
Tickers
NBIX
Tags
General
Benzinga
Biotech
From
Benzinga
Neurocrine Pens $2.6B Pact With Sosei Heptares For Neuro Targets
November 22, 2021
Tickers
NBIX
Tags
Health Care
News
Briefs
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021
November 19, 2021
Tickers
ABCL
ACGL
AIG
AJG
Tags
BIIB
DAL
VIPS
From
Benzinga
Mobile Mental Health: Coming to a Home Near You?
November 18, 2021
Tickers
KTTA
LLY
NBIX
Tags
Pasithea
Market News
NBIX
From
Benzinga
Analyst Ratings For Neurocrine Biosciences
November 17, 2021
Tickers
NBIX
Tags
Benzinga
NBIX
BZI/AAR
From
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
